Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences;Litio e anticonvulsivanti nel trattamento della mania e nella profilassi delle ricorrenze

Rivista di Psichiatria

Volumn 46, Issue 3, 2011, Pages 172-181

  Salvi, Virginio ^a   Cat Berro, Alberto ^a   Bechon, Elisa ^a   Bogetto, Filippo ^a   Maina, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bipolar disorder; Mania; Pharmacotherapy

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

BIPOLAR DISORDER; DEPRESSION; DRUG EFFICACY; GOLD STANDARD; HUMAN; LONG TERM CARE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; TREATMENT FAILURE;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; LITHIUM COMPOUNDS; RECURRENCE; TIME FACTORS;

EID: 80051523282     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Bauer MS, Mitchner L. What is a "mood stabilizer"? An evidence- based response. Am J Psychiatry 2004; 161: 3-18.
2. Bowden CL. New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology 1998; 19: 194-9. (Pubitemid 28302576)
3. Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 2002; 63: 146-51. (Pubitemid 34173852)
4. Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, et al. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 2003; 60: 1218-26. (Pubitemid 37494075)
5. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (Revision). Am J Psychiatry 2002; 159 (suppl. 4): 1-50.
6. Suppes T, Dennehy EB, Swann AC, et al. Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry 2002; 63: 288-99. (Pubitemid 34456355)
7. Grunze H, Vieta E, Goodwin G, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2010; 11: 81-109.
8. Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas Implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005; 66: 870-86. (Pubitemid 41032829)
9. Yatham LN, Kennedy SH, Shaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11: 225-55.
10. Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry 1963; 109: 56-65.
11. Stokes PE, Shamoian CA, Stoll PM, Patton MJ. Efficacy of lithium as acute treatment of manic- depressive illness. Lancet 1971; 1: 1319-25.
12. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271: 918-24. (Pubitemid 24083217)
13. Bowden CL, Grunze H, Mullen J, et al. A randomized, doubleblind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005; 66: 111-21.
14. Kushner SF, Khan A, Lane R, Olson WH. Topiramate monotherapy in the management of acute mania: results of four doubleblind placebo-controlled trials. Bipolar Disord 2006; 8: 15-27. (Pubitemid 43356017)
15. Johnson G, Gershon S, Hekimian LJ. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report. Comprehensive Psychiatry 1968; 9: 563-73.
16. Spring G, Schweid D, Gray C, Steinberg J, Horwitz M. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry 1970; 126: 1306-10.
17. Johnson G, Gershon S, Burdock EI, Floyd A, Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry 1971; 119: 267-76.
18. Prien RF, Caffey EM Jr, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study group. Arch Gen Psychiatry 1972; 26: 146-53.
19. Platman SR. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry 1970; 127: 351-3.
20. Takahashi R, Sakuma A, Itoh K, Itoh H, Kurihara M. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Arch Gen Psychiatry 1975; 32: 1310-8.
21. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108-11.
22. Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14: 339-43. (Pubitemid 29531382)
23. Niufan G, Tohen M, Qiuqing A, et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. J Affect Disord 2008; 105: 101-8. (Pubitemid 350245681)
24. Li H, Ma C, Wang G, Zhu X, Peng M, Gu N. Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. Curr Med Res Opin 2008; 24: 1-10. (Pubitemid 351160233)
25. Storosum JG, Wohlfarth T, Schene A, Elferink A, Van Zwieten BJ, Van Den Brink W. Magnitude of effect of lithium in shortterm efficacy studies of moderate to severe manic episode. Bipolar Disord 2007; 9: 793-8. (Pubitemid 350215104)
26. Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54: 37-42. (Pubitemid 27044696)
27. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Mania: differential effects of previous depressive and manic episodes on response to treatment. Acta Psychiatr Scand 2000; 101: 444-51. (Pubitemid 30365566)
28. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991; 48: 62-8.
29. Bowden CL, Swann AC, Calabrese JR, et al. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 2006; 67: 1501-10. (Pubitemid 44787431)
30. Hirschfeld RM, Bowden CL, Vigna NV, Wozniak P, Collins M. A randomized, placebo-controlled,multicenter study of divalproex sodium extended-release in the acute treatment of mania. J Clin Psychiatry 2010; 71: 426-32.
31. McElroy SL, Martens BE, Creech RS, et al. Randomized, double- blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania. J Clin Psychiatry 2010; 71: 557-65.
32. Hirschfeld RM, Allen MH, McEvoy JP, Keck PE Jr, Russell JM. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 1999; 60: 815-8.
33. Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2002; 63: 1148-55. (Pubitemid 36084060)
34. Tohen M, Baker RW, Altshuler LL, et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002; 159: 1011-7. (Pubitemid 34586948)
35. Tohen M, Vieta E, Goodwin GM, et al. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. J Clin Psychiatry 2008; 69: 1776-89.
36. Langosch JM, Drieling T, Biedermann NC, et al. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. J Clin Psychopharmacol 2008; 28: 555-60.
37. Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry 2003; 64: 841-6. (Pubitemid 36897222)
38. Lerer B, Moore N, Meyendorff E, Cho SR, Gerson S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987; 48: 89-93. (Pubitemid 17047795)
39. Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988; 153: 198-204.
40. Okuma T, Yamashita I, Takahashi R, et al. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 1990; 23: 143-50. (Pubitemid 20304128)
41. Small JG, Klapper MH, Milstein V, et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991; 48: 915-21.
42. Okuma T, Inanaga K, Otsuki S, et al. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a doubleblind controlled study. Psychopharmacology (Berl) 1979; 66: 211-7. (Pubitemid 10173616)
43. Brown D, Silverstone T, Cookson J. Carbamazepine compared to haloperidol in acute mania. Int Clin Psychopharmacol 1989; 4: 229-38.
44. Weisler RH, Kalali AH, Ketter TA; the SPD417 Study Group. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65: 478-84.
45. Weisler RH, Keck PE Jr, Swann AC, et al. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2005; 66: 323-30. (Pubitemid 40476755)
46. Ketter T, Wang PW, Nowakowska C, Marsh W, Bonner J. Treatment of acute mania in bipolar disorder. In: Ketter T (ed). Advances in the treatment of bipolar disorder. Washington, DC: American Psychiatric Publishing, 2005.
47. Goodwin GM, Young AH. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003; 17: 149-73. (Pubitemid 36753531)
48. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 2004; 38: 280-305.
49. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59: 62-9. (Pubitemid 34044408)
50. Tohen M, Bowden CL, Smulevich AB, et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry 2008; 192: 135-43. (Pubitemid 351269648)
51. Sachs G, Chengappa KN, Suppes T, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004; 6: 213-23. (Pubitemid 38702297)
52. Yatham LN, Paulsson B, Mullen J, Vagero AM. Quetiapine versus placebo in combination with lithium or divalproex for the treat ment of bipolar mania. J Clin Psychopharmacol 2004; 24: 599- 606.
53. Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, VågeröM. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Int Clin Psychopharmacol 2007; 22: 212-20. (Pubitemid 46801944)
54. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146-54. (Pubitemid 34743254)
55. Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 2003; 182: 141-7. (Pubitemid 36177237)
56. Weisler R, Warrington L, Dunn J, Giller EL, Mandel FS. Adjunctive ziprasidone in bipolar mania: short and long-term data. Presented at the American Psychiatric Association 2004 Annual Meeting. 2004 May 1-6; New York (NY). Abstract NR358.
57. Vieta E, T'joen C, McQuade RD, et al. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. Am J Psychiatry 2008; 165: 1316-25.
58. Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE Jr. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006; 67: 509-16. (Pubitemid 43764227)
59. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007; 64: 442-55. (Pubitemid 46556468)
60. Roy Chengappa KN, Schwarzman LK, Hulihan JF, Xiang J, Rosenthal NR; Clinical Affairs Product Support Study-168 Investigators. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. J Clin Psychiatry 2006; 67: 1698-706. (Pubitemid 44955149)
61. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2 (3 Pt 2): 249-55.
62. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217-22. (Pubitemid 38419270)
63. Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321: 1489-93. (Pubitemid 20015538)
64. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000; 61: 841-50.
65. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400. (Pubitemid 36403000)
66. Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013-24. (Pubitemid 37158246)
67. BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-95.
68. Kleindienst N, Greil W. Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder. Psychol Med 2002; 32: 493-501. (Pubitemid 34308793)
69. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000; 57: 481-9. (Pubitemid 30257262)
70. Bowden CL. Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychiatry 2000; 61 (suppl. 9): 35- 40.
71. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20- month, double- blind, maintenance trial of lithium versus divalproex in rapid- cycling bipolar disorder. Am J Psychiatry 2005; 162: 2152-61 (Pubitemid 41598271)
72. Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA; LitCar Group. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003; 64: 144-51. (Pubitemid 36268316)
73. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58: 470-8. (Pubitemid 27527442)